Penicillin/β-lactamase inhibitor-susceptible MRSA. As part of an earlier study 16 , we identified a mecA-positive MRSA isolate that 
T he β-lactam family of antibiotics is one of the most widely used and clinically important groups of antibiotics 1 . Resistance to β-lactam antibiotics in Staphylococcus aureus is either mediated by the acquisition of the blaZ gene encoding a β-lactamase, or in methicillin-resistant S. aureus (MRSA) from the acquisition of an alternative penicillin-binding protein 2a (PBP2a) with a low affinity for β-lactam antibiotics, resulting in resistance to most β-lactams 2 . PBP2a is encoded by mecA or mecC (PBP2c) carried on a mobile genetic element known as a staphylococcal cassette chromosome mec (SCCmec) 3, 4 , and is regulated by two independent regulatory systems (mecI-mecR-mecR2 and blaI-blaR) and multiple chromosomal genes 5 . Countering resistance to β-lactams was first achieved by the development of β-lactamase-resistant β-lactams such as methicillin 6 , and subsequently by the development of β-lactamase inhibitors 7 . Unfortunately, MRSA is both resistant to methicillin antibiotics and insensitive to β-lactamase inhibitors. However, in the early 1990s, β-lactams and β-lactamase inhibitors were tested against MRSA [8] [9] [10] [11] , with success both in vivo and clinically 12 . Recently, different approaches to restoring susceptibility to β-lactams have been investigated, including using multiple antibiotics to exploit collateral sensitivity (resistance to one antibiotic increases sensitivity to another) [13] [14] [15] . We recently demonstrated that the small subset of MRSA isolates with the mecC gene are susceptible to penicillins and β-lactamase inhibitors, as the mecC-encoded PBP2c does not mediate resistance to penicillins 16 . Here, we demonstrate that, unexpectedly, a significant proportion of all clinical mecA-positive MRSA isolates from diverse lineages are susceptible to penicillins and β-lactamase inhibitors. These findings could provide the basis for new treatment options for susceptible MRSA infections using antibiotics that are already licenced.
exhibited increased susceptibility to penicillin in the presence of clavulanic acid (a β-lactamase inhibitor) (Fig. 1a) . We screened a selection of whole-genome-sequenced MRSA isolates (n = 110) from different clinically relevant clonal lineages for the same increase in susceptibility (≥10 mm increase in the zone of inhibition in the presence of 15 μg ml −1 clavulanic acid, compared with penicillin alone). A total of 55 (50.0%) isolates from different lineages were susceptible to penicillin-clavulanic acid (Supplementary Table 1 ). We determined the minimum inhibitory concentration (MIC) for penicillin for a subset of isolates, which showed that the MIC was reduced below the European Committee on Antimicrobial Susceptibility Testing (EUCAST)/Clinical and Laboratory Standards Institute (CLSI) break point (≤0.125 μg ml ; ref. 17 and http://www.eucast.org) in 10 of the 14 susceptible isolates, and none of the 10 resistant isolates (Fig. 1b) . Two other β-lactam inhibitors-sulbactam and tazobactam-also increased susceptibility to penicillin (Supplementary Fig. 1 ), suggesting that the effect of clavulanic acid was due to inhibition of the staphylococcal β-lactamase. Next, we evaluated whether the increase in susceptibility was penicillin specific by screening isolates against different β-lactam antibiotics in the presence of clavulanic acid (Fig. 1c,d ). This revealed that the penicillin-clavulanic acid-susceptible isolates showed the greatest increase in susceptibility to penicillins (benzyl-and aminopenicillins) ( Fig. 1d ) and were broadly more susceptible to cephalosporins (except ceftaroline) and carbapenems than the resistant isolates (Fig. 1c) . In contrast, the presence of clavulanic acid produced only minor increases in susceptibility in the resistant isolates (Fig. 1c) .
Substitutions in PBP2a mediate increased penicillin susceptibility.
Benzyl-and aminopenicillins bind reasonably well to PBP2a compared with the isoxazolyl penicillins (oxacillin) and cephalosporins 18 . As amino acid substitutions in PBP2a mediate resistance to fifth-generation cephalosporins 19 , in the absence β-lactamase activity, we hypothesized that, inversely, increased susceptibility to penicillins might be mediated by PBP2a substitutions. We examined the PBP2a amino acid sequences of the 110 isolates (Supplementary Table 1 ). This revealed that 80.0% (44/55) of the penicillin-clavulanic acid-susceptible isolates had either an E246G (PBP2a
246G
; n = 37) or an M122I (PBP2a
122I
; n = 7) substitution in the allosteric domain of PBP2a 20 . In contrast, only 29.1% (16/55) of the resistant isolates had the PBP2a 246G substitution. Phylogenetic analysis of PBP2a indicated that 246E is present in the S. aureus COL genome (M122I was absent), an early MRSA strain isolated in the 1960s, with origins in the 1940s 21, 22 , suggesting that this might be the ancestral or 'wild-type' form ( Supplementary Fig. 2 ).
Next, we tested the effect of the PBP2a substitutions experimentally. We deleted mecA (PBP2a) in isolates from two S. aureus lineages: ST398 (EC139) 23 and USA300/ST8 (BCVA289) 24 (both PBP2a 246G and blaZ positive) and introduced plasmid-borne copies of three mecA alleles: the putatively resistant 'wild-type' mecA 246E and the two alleles associated with susceptibility: mecA 122I and mecA 246G . All of the complemented strains were resistant to penicillin alone (MICs > 20 μg ml
; break point > 0.125μg ml −1 ) (Fig. 2a) . For penicillin-clavulanic acid, the mecA 246E strains were resistant, with MICs of 1 μg ml −1 (Fig. 2a ). The strains with mecA 246G were susceptible, with MICs of 0.125 μg ml . Similarly, strains with mecA 122I had MICs of 0.125 and 0.25 μg ml −1 for USA300 and ST398 backgrounds, respectively. No difference in susceptibility was seen for cefoxitin (a cephalosporin), confirming that the effect of the substitutions was limited to penicillin susceptibility (Supplementary Table 2) .
A combination of mecA promoter mutations and PBP2a substitutions mediates susceptibility. We reasoned that the PBP2a substitutions might cause an increase in the affinity of PBP2a for penicillin. We tested PBP2a
246E
, PBP2a 246G and PBP2a 122I in a bocillin competition assay to determine their relative binding affinities for penicillin (Fig. 2b) . This identified that all three variants had a similar affinity for penicillin, with median inhibitory concentrations (IC 50 ) (±s.e.m.) of 10.63 ± 0.53 µg ml −1 for PBP2a 246G , 12.11 ± 1.07 µg ml
for PBP2a 122I and 9.06 ± 2.70 µg ml −1 for PBP2a 246E (Fig. 2b) . As susceptibility testing had been carried out in the presence of clavulanic acid, we repeated the bocillin binding assays with 15 µg ml −1 clavulanic acid. In the presence of clavulanic acid, the wild-type PBP2a 246E had a twofold higher IC 50 ), which were virtually unaffected (Fig. 2c) .
To confirm the consistency of association between the two PBP2a substitutions and phenotypic susceptibility, we determined the penicillin and penicillin-clavulanic acid MICs for 274 whole-genome-sequenced isolates from a range of S. aureus lineages (Supplementary Table 3 ). We then combined the data with the original 24 isolates with MIC data (Fig. 1b) and plotted the frequency distributions of the penicillin and penicillin-clavulanic acid MICs (Fig. 2d,e) . In the absence of a clinical break point for penicillin-clavulanic acid, we determined a tentative epidemiological (wild-type) cut-off (ECOFF) using a statistical method based on mixture models 25, 26 . This supported setting the ECOFF between 2.0 and 3.0 µg ml −1 (2.449, rounded down to 2.0 µg ml −1 ) for penicillin in the presence of 15 µg ml −1 clavulanic acid (Fig. 2d) . The same method supported an ECOFF between 0.19 and 0.25 µg ml −1 (0.218, rounded down to 0.19 µg ml −1 ) for penicillin alone, which is within one doubling dilution of the EUCAST clinical break point (http://www.eucast.org; Fig. 2e ). Using the ECOFF of ≤2.0 μg ml
as the cut-off, 213 (71.5%) isolates were classified as susceptible to penicillin-clavulanic acid, of which only 176 (82.6%) had either a 246G or 122I substitution. This indicated that 37 (17.4%) isolates were susceptible despite having no PBP2a substitution. Conversely, only 37 (43.5%) of the resistant isolates (MIC > 2 µg ml −1 ) had a 246G substitution.
Incomplete congruence between PBP2a substitutions and penicillin-clavulanic acid susceptibility led us to search for further mutations involved in susceptibility. We hypothesized that higher levels of PBP2a expression might overcome the effect of the PBP2a substitutions. We screened the same 298 isolates for mutations in the mecA promoter region. This identified two mutations that correlated with susceptibility.
The first mutation was a G to T transversion in the mecA ribosomal binding site (RBS), seven nucleotides upstream from the mecA start codon (Fig. 3a) . Isolates with the mecA [−7] :T allele had a median penicillin-clavulanic acid MIC of 0.125 μg ml −1 (range < 0.016-6) compared with a median of 8 μg ml −1 (range: 0.023-96) for isolates with the 'wild-type' mecA [−7] :G. Previous work has demonstrated that despite being in the RBS, the T allele results in lower mecA transcript and PBP2a expression levels 27 . We compared relative levels of mecA expression by reverse-transcription quantitative PCR (RT-qPCR) in isolates from phylogenetically separate lineages with the mecA [−7] :G (n = 7) allele with isolates with the mecA [−7] :T allele (n = 6) (Fig. 3b) . Isolates with the T allele had a statistically significantly lower relative expression (mean relative expression: 3.24) than isolates with the G allele (mean: 7.00) (P = 0.0048) (Fig. 3b) . The second mutation was a C to T transition in the mecA -10 box, 33 nucleotides upstream from the mecA start codon (mecA[−33]:T) (Fig. 3a) . Isolates with this mutation had a median penicillin-clavulanic acid MIC of 0.047 μg ml −1 (range: <0.016-0.125). The C to T transition causes the generation of a perfect palindrome within the MecI-BlaI binding site, which lowers mecA transcript and PBP2a expression levels 27, 28 . Three isolates from distinct lineages with the mecA [−33] :T mutation had a mean relative expression rate of 0.27, suggesting that the C to T transition results in very low levels of mecA expression in the tested isolates (Fig. 3b) ) (Fig. 3a) , we identified six genotypes. These were used to annotate the MIC distributions for penicillin and penicillin-clavulanic acid (Fig. 3c,d ). For penicillin-clavulanic acid, the genotypes split clearly into the bimodal distribution (Fig. 3c) . The majority of isolates with mecA [−7] :G (henceforth, resistant 1) and mecA [−7] :G | E246G (resistant 2) genotypes were found in the modal peak to the right, with MICs above the ECOFF of ≥2 μg ml ). Isolates with susceptible genotypes had lower penicillin MICs in the absence of clavulanic acid than those with resistant genotypes (Fig. 3c,d ). The use of the six genotypes to predict susceptibility using the ECOFF as a break point was accurate in 94.6% (282/298) of isolates, with a 0.34% (1/298) very major error rate (defined as isolates that were phenotypically resistant but genotypically predicted to be susceptible) and a 5.0% (15/298) major error rate (phenotypically susceptible, but genotypically predicted resistant).
Finally, we investigated whether the presence of the six different types of class A staphylococcal ß-lactamases (types A-F) or blaZ expression levels might affect penicillin-clavulanic acid susceptibility 16 . There was no association between the β-lactamase type and susceptibility that was not better explained by the six genotypes (Supplementary Table 3 and Fig. 3a) . Nor was there any significant association (P = 0.43) between blaZ expression and susceptibility in 20 isolates (11 susceptible; 9 resistant) as measured by RT-qPCR ( Supplementary Fig. 3b ).
Clinical prevalence and epidemiology. We sought to quantify the frequency of penicillin-clavulanic acid susceptibility in clinical MRSA isolates. We tested a collection of 270 S. aureus isolates (MRSA, n = 218; methicillin-susceptible S. aureus (MSSA), n = 52) collected by the Danish Staphylococcus Reference Laboratory as part of bacteraemia surveillance 29 (Supplementary Table 4 ). Isolates were classified as resistant or susceptible based on the ECOFF of ≤2.0 μg ml −1 penicillin in the presence of 15 μg ml −1 clavulanic acid. All MSSA isolates and 84.9% (185/218) of the MRSA isolates had an MIC below the ECOFF. The MRSA isolates were from a variety of lineages, as inferred from spa typing, including clonal complex (CC1, CC5, CC8, CC30 and CC80). We then screened 2,282 whole-genome-sequenced MRSA isolates from Cambridge, United Kingdom for the six genotypes (Fig. 4a) 
30
. None of the isolates in this collection had the susceptible 4 genotype. Overall, 25.0% of isolates had one of the three remaining putative susceptible genotypes (Fig. 4a) . The dominant UK MRSA sequence type is ST22 (EMRSA-15); if the CC22 isolates (70.4% of isolates) were excluded, 82.8% (n = 610) had one of three susceptible genotypes (Fig. 4a) . Lineages with a high abundance of susceptible genotypes included CC1, CC5, CC8, CC30 and CC59 (Fig. 4a) . Importantly, 56 of the CC8 isolates (from 24 patients) were USA300, which is the dominant clonal lineage in the United States 31 . All 56 USA300 isolates had the susceptible 2 genotype and a penicillin-clavulanic acid MIC below the ECOFF (Supplementary Table 3 ). We performed a phylogenetic analysis of 580 CC8 isolates, including 485 USA300 isolates (457 MRSA; 28 MSSA) from across the United States 32, 33 . All 457 of the USA300 MRSA isolates had the susceptible 2 (mecA[−7]:G-T | E246G) genotype carried on a SCCmec type IVa (n = 455) or IVb element (n = 1) (one isolate was non-SCCmec typeable), suggesting that the majority of the USA300 population is susceptible to penicillin-clavulanic acid (Fig. 4b) . We then screened 23 USA300 isolates, distributed across the phylogeny (isolated in New York 33 ) for penicillin-clavulanic acid susceptibility (Fig. 4b ). All had an MIC below the ECOFF (<2 µg ml ) can survive at much higher MICs 34 . We tested representative isolates for all six penicillin-clavulanic acid susceptibility genotypes in a population analysis for their susceptibility profile to penicillin-clavulanic acid. Isolates representing the four susceptible genotypes all displayed heterogeneous resistance to penicillin-clavulanic acid (Fig. 5a ). Colony-forming units (c.f.u.) were drastically reduced at low concentrations of penicillin (0.12-1 µg ml −1 ), and susceptible isolates had a median population MIC of 12 µg ml −1 (range: 0.48-32) (Fig. 5a) . Notably, for four isolates from three different genotypes (susceptible 1, 3 and 4), the entire population was completely inhibited by 4 µg ml Relative mecA expression * ** isolates were unaffected at the lower penicillin concentration range (0.12-1 µg ml
) and had a higher median population MIC of 64 µg ml −1 (range: 64-128 µg ml −1
), which was greater than the susceptible isolates (Fig. 5a ). Highly resistant cells (MIC ≥ 4 µg ml ) were also present at higher frequencies (1-10
) than susceptible isolates.
Pencillin-clavulanic acid is effective for MRSA treatment in vivo. Next, we sought to demonstrate efficacy in physiologically relevant infection models in which highly resistant cells would be present. First, we used a wax moth larvae model of infection. Larvae were infected with four different MRSA isolates: two with a resistant genotype (both ST22; resistant 1) and two with a susceptible genotype (ST398 and ST8 (USA300); susceptible 2). Treatment at approximate human dosages was with penicillin, penicillin-clavulanic acid, amoxicillin, amoxicillin-clavulanic acid, vancomycin or phosphate buffered saline (PBS; vehicle). Only vancomycin offered any improvement in survival for the two resistant isolates (Fig. 5b,c) . In contrast, for the two susceptible isolates, both penicillin-clavulanic acid and amoxicillin-clavulanic acid increased survival compared with penicillin or amoxicillin alone, increasing the median survival times by 40 h (Fig. 5d,e) . Given that amoxicillinclavulanic acid is clinically available, we further tested its efficacy in a more physiologically relevant, higher infective dose (1 × 10 7 c.f.u.) murine thigh infection model, with approximate human dosages using a USA300 strain (strain: MRSA 43484 (ref. 35 ), Susceptible 2, penicillin-clavulanic acid MIC: 0.19 μg ml −1 , see Supplementary  Fig. 4 for population analysis of this strain and Fig. 4b for its location in the USA300 phylogeny). Treatment with amoxicillin alone in a dose range of 10-100 mg kg −1 did not reduce the bacterial loads compared with vehicle treatment, whereas 100 mg kg −1 amoxicillin in combination with 20 mg kg −1 clavulanic acid significantly reduced the bacterial loads to a similar level as 40 mg kg −1 vancomycin (Dunnett's multiple comparisons test; P < 0.0001) (Fig. 5f) , showing the efficacy of amoxicillin-clavulanic acid as a treatment in a high-dose infection model. PBP2a substitutions provide a growth advantage in the presence of penicillin. As the acquisition of mecA (PBP2a) in a SCCmec element can exhibit significant fitness costs 36 , and affect toxicity 37 and biofilm formation 38 , we hypothesized that the PBP2a substitutions might confer a fitness advantage. We found no significant difference in biofilm formation or toxicity to human monocytic cells between any of the three PBP2a variants in two strain backgrounds ( Supplementary Fig. 6 ). We then investigated the effect of the PBP2a substitutions on general fitness in three lineages (ST22, USA300/ST8 and ST398) assayed by growth in a minimal medium, and in the presence of penicillin. In minimal medium, there were only minor differences (Fig. 6a,c,e) , with the USA300 strain (BCV289) complemented with mecA 246G growing marginally better in the early exponential phase than mecA 246E or mecA 122I (Fig. 6a) . In the ST22 (A75) background, the mecA 246E strain grew slower during exponential growth than the other backgrounds (Fig. 6e) . In the presence of penicillin, in all three strain backgrounds, the isolates complemented with mecA 246G grew better than the other two variants (Fig. 6b,d,f) . This was most pronounced in the ST398 background (EC139), in which the mecA 246G strain grew considerably better in the exponential phase, reached a higher optical density, and grew with a reduced doubling time of 5.33 h (95% confidence interval (CI): 5.28-5.38) compared with either mecA 246E (doubling time: 6.65; 95% CI: 6.62-6.69) or mecA 122I (doubling time: 6.92; 95% CI: 6.89-6.96) (Fig. 6d) . This showed that complementation with mecA 246G provided a growth advantage in the presence of penicillin, but the magnitude of this effect was influenced by strain background.
Discussion
We show that a significant proportion of clinical MRSA isolates are susceptible to a combination of penicillins and a β-lactamase inhibitor. Susceptibility is due to one of two different mutations in the mecA promoter region that both lower mecA (PBP2a) expression, and in the majority of isolates, by an additional substitution . Modelling of PBP2a shows that position 246 is located near the allosteric site, but does not indicate any clear mechanism for the increased affinity for penicillin ( Supplementary Fig. 7 and Supplementary Discussion). In some isolates, an RBS mutation alone appeared to be sufficient to mediate susceptibility, although given the complexity of the regulation of β-lactam resistance in MRSA, other genes might be involved 5 . Crucially, the PBP2a 246G substitution provides a fitness benefit for growth in the presence of penicillin, suggesting that susceptibility to penicillin and β-lactamase inhibitors is a probable case of collateral sensitivity 39 , which evolved due to selective pressure for maintaining the balance between fitness and resistance.
In our susceptibility assays, we used Iso-Sensitest agar (ISA) rather than Müller-Hinton agar (MHA), as is currently recommended by CLSI and EUCAST (http://www.eucast.org) 18 , because ISA was the recommended media for penicillin by the British Society for Antimicrobial Chemotherapy (BSAC) at the beginning of the study 40 .
Comparison of susceptibility to penicillin-clavulanic acid on ISA versus MHA revealed that a number of isolates that were susceptible on ISA remained resistant on MHA (Supplementary  Table 5 ), including isolates that responded to treatment in vivo (Fig. 5b-e) . This suggests that MHA is not the optimum media for the detection of susceptibility of penicillins and β-lactamase ] of the different strains at various concentrations of penicillin G in the presence of 15 µg ml −1 clavulanic acid on Iso-Sensitest plates. The plotted points are the means of three technical replicates (biological replicates for BCVA289 and 0081 are shown in Supplementary Fig. 4) . b-e, Survival curves for wax moth larvae (G. mellonella) infected with ~1.5 × 10 inhibitors, which is supported by a recent study that revealed that MHA failed to detect susceptibility to multiple antibiotic classes that were effective in vivo 41 . Our data also highlight the risk of using a single antibiotic (for example, cefoxitin for MRSA) to determine the resistance to an entire antibiotic class, potentially missing unexpected susceptibilities.
Both in vitro and in vivo, penicillins and clavulanic acid were efficacious at physiologically achievable concentrations 42 . In the absence of a clinical break point, pharmacokinetic-pharmacodynamic (PK-PD) break points can be used to infer susceptibility 43 . The tentative ECOFF wild-type cut-off of ≤2.0 µg ml−1 penicillin in the presence of 15 μg ml ) of the EUCAST PK-PD break point (http://www.eucast.org). Large numbers of isolates had much lower MICs, and had amoxicillin-clavulanic acid zone diameters greater than the break point for other pathogenic species (http://www.eucast.org; Supplementary Tables 1, 3 and 4). Previous studies have reported the successful use of penicillins and β-lactamase inhibitors for the treatment of MRSA in rabbits and rats, and for human infections 11, [44] [45] [46] . This work provides a mechanistic explanation for efficacy in these studies, although there have been previous conflicting reports 9 . While it is unlikely that penicillins and β-lactamase inhibitor combinations would be used as a monotherapy, they would be an attractive additional therapeutic option for hard-to-treat infections, such as multidrug-resistant MRSA 47 , particularly as β-lactams synergize with vancomycin and daptomycin 48, 49 . PK-PD modelling studies, including an assessment of highly resistant cells during treatment, are now needed to determine the optimum dosing strategy required for sustained efficacy before appropriate clinical trials could be conducted.
Our findings show that cryptic susceptibilities to already licensed and inexpensive antibiotics may emerge within constantly evolving bacterial populations, which then can be exploited for the treatment of antibiotic-resistant pathogens. 
Fig. 6 | PBP2a
246G substitution provides an increased growth rate in the presence of penicillin. a-f, Growth curves for strain BCV289∆mecA grown in SSM9PR minimal medium (a) and SSM9PR with 16 μg ml −1 penicillin (b), strain EC139∆mecA grown in SSM9PR minimal medium (c) and SSM9PR with 16 μg ml −1 penicillin (d), and strain A75∆mecA grown in SSM9PR minimal medium (e) and SSM9PR with 8 μg ml −1 penicillin (f). Lines are coloured depending on the vector the two strains were complemented with (orange, vector-only control; green, vector expressing mecA 
Methods
Media and culture conditions. The bacterial strains and plasmids used in this study are described in Supplementary Tables 5 and 6 . For routine culture, Escherichia coli was grown in lysogeny broth or on lysogeny broth agar (Oxoid) at 37 °C. S. aureus was grown on tryptone soy agar or Columbia blood agar, or in tryptone soy broth (TSB; Oxoid) at 28 or 37 °C accordingly. E. coli and S. aureus media were supplemented with 10 µg ml −1 chloramphenicol (Cm10) as appropriate. For growth curve studies, S. aureus strains were grown in SSM9PR minimal medium (1× M9 salts, 2 mM MgSO 4 , 0.1 mM CaCl 2 , 1% glucose, 1% casaminoacids, 1 mM thiamine hydrochloride and 0.05 mM nicotinamide) at 37 °C 50 .
Isolate selection. For the 110 sequenced isolates in Supplementary Table 1 , isolates were selected from sequenced isolates in our laboratory collections to provide as broad a selection of isolates as possible from different clinically relevant lineages (multilocus sequence types (ST1, ST5, ST8 ST22, ST36, ST45, ST80, ST88, ST239 and ST398), with an obvious bias towards lineages that dominate in the United Kingdom (for example, 40 isolates from ST22, which is the dominant lineage in the United Kingdom). For the additional 274 isolates that were combined with 24 of the original isolates with MIC data (from the previous 110), we again tried to select isolates from our laboratory collections that broadly covered a selection of clinically relevant MRSA lineages including clonal complexes CC1, CC5 and CC8 (including 56 UK USA300 isolates), CC22, CC30, CC45, CC59, CC72, CC80, CC97, CC239 and CC398 among others). For lineages with multiple isolates (CC1, n = 25; CC5, n = 29; CC22, n = 91; CC59, n = 18; CC45, n = 15; and CC30, n = 20), we used previously generated whole-genome phylogenies 30 to select isolates broadly across the phylogeny, as well as selecting isolates from the same clades.
Antimicrobial susceptibility testing. Inocula were prepared by the growth method. At least four morphologically similar colonies were touched with a sterile loop and transferred into ISA (Oxoid). Inoculated broth was incubated at 37 °C with 200 r.p.m. shaking until the visible turbidity reached the 0.5 McFarland standard. For disk diffusion and Etest method testing, the 0.5 McFarland standard broth was diluted 1:10 in distilled water before spreading onto agar plates. For microbroth dilution for MIC, the broth was diluted 1:100 in ISA for inoculation.
Disk diffusion susceptibility testing was carried out according to BSAC criteria 40 . Temocillin disks were purchased from Mast Group. All other antibiotic disks were purchased from Oxoid. For the clavulanic acid assay, 15 µg ml clavulanic acid (Sigma-Aldrich) was added to ISA or MHA (Oxoid), as appropriate. After applying the antibiotic disks, all plates were incubated at 35 °C for 20 h before inhibition zones were measured. Oxacillin disk diffusion was also performed on MHA with 2% NaCl at 30 °C for 24 h. For disk testing with clavulanic acid, susceptibility was defined as a ≥10 mm increase of the zone of inhibition in the presence of 15 μg ml −1 clavulanic acid. For mecA complemented strains, ISA was supplemented with 200 ng ml −1 anhydrotetracycline (Atc; Sigma-Aldrich) to induce expression of mecA from pXB01-a modified version of the tetracyclineinducible expression vector pRMC2 (ref. 16 ). Microbroth dilution for MIC was performed according to BSAC guidelines 51 . The antibiotic ranges were prepared in ISA a step higher than the final concentrations of 0.015-128 µg ml −1 for penicillin and 1-32 µg ml −1 for cefoxitin. A 96-well cell culture plate (Greiner Bio-One; CELLSTAR) was loaded with appropriate antibiotic dilutions. For each test isolate, 75 µl of each antibiotic dilution were added to a row of wells, and 75 µl of diluted test isolate culture was added to the wells. Each isolate was tested in triplicate. The 96-well plate was then placed in a plastic bag to minimize evaporation and incubated at 35 °C for 20 h. Penicillin and cefoxitin Etest antimicrobial susceptibility testing on selected MRSA isolates was performed according to the manufacturer's guidelines. The medium used for each Etest was ISA with or without 15 µg ml −1 clavulanic acid. Etest strips were purchased from BioMérieux. Table 7) were generated by allelic exchange with the temperature-sensitive vector pIMAY, as described previously 52 . The primers used for mecA deletion are listed in Supplementary  Table 8 . Upstream (AB) and downstream sequences (CD) of the S. aureus gene to be deleted were amplified with primers A/B or C/D using KOD Hot Start DNA Polymerase (Merck). The PCR products AB and CD were used as templates to obtain deletion construct AD with primers A/D in a splicing overlap extension PCR. Product AD was digested with restriction enzymes KpnI and SacI and ligated to pIMAY digested with the same enzymes. The resulting plasmids were designated pIMAYΔmecA. The plasmids were transformed into E. coli DC10B (a dcm deletion mutant of DH10B), allowing the plasmid to be directly transferred into S. aureus strains 52 . Plasmid DNA extracted from DC10B was then electroporated into recipient strains to create knockout mutants.
Construction of S. aureus gene deletion and complementation mutants. mecA deletion mutants in mecA-MRSA strains (Supplementary
For complement expression of mecA, the genes were cloned into expression plasmid pXB01-a derivate of tetracycline-inducible expression vector pRMC2 with the blaZ gene deleted 53 . The mecA gene variants including the ribosome binding site were amplified from genomic DNA with the primers mecA-FKpnI/mecA-R-SacI. PCR products were digested with KpnI and SacI and ligated with the pXB01 vector cleaved with the same enzymes, generating plasmids pmecA 246E , pmecA 246G and pmecA 122I .The plasmids were transformed into E. coli DC10B, and plasmid DNA was then extracted and electroporated into mecA deletion strains for complementation with expression induced with 200 ng ml −1 Atc.
Antimicrobial susceptibility testing of Danish clinical isolates.
Antimicrobial susceptibility testing was performed on a selection of clinical isolates obtained from the Danish surveillance of MRSA and S. aureus causing bacteraemia. The selection was based on a total of 270 isolates, including 100 isolates (52 MSSA; 48 MRSA) from 2011 on which whole-genome sequencing data were previously obtained and 170 non-CC398 MRSA isolates that had been consecutively received in 2016. spa types were obtained for all isolates. Antimicrobial susceptibility testing was performed as described above except that 0.5 McFarland inoculum was prepared using a densitometer, and ISA plates with and without 15 µg ml −1 clavulanic acid were purchased as custom-made plates (SSI Diagnostica).
Expression and purification of PBP2a variants in E. coli. PBP2A variants (PBP2a E246 , PBP2a
E246G and PBP2a M122I from MRSA strains RVC5, BCVA289 and ARARH150, respectively; residues 26-668, with a G26M mutation) were overexpressed using the auto-induction expression method at 25 °C 54 . Cells were harvested by centrifugation after 20 h of expression and lysed using BugBuster (Novagen; Merck Millipore) containing 10 U ml −1 of benzonase nuclease (Novagen; Merck Millipore) and EDTA-free Protease Inhibitor Tablets (Pierce Biotechnology; Thermo Fisher Scientific), following the manufacturer's instructions. After cell disruption, the lysates were cleared, and the soluble proteins were purified using HisPur Ni-NTA Resin columns (Pierce Biotechnology; Thermo Fisher Scientific) under native conditions, according to the manufacturer's instructions. The expression and purification yields were monitored by sodium dodecyl sulfate polyacrylamide gel electrophoresis. The most concentrated elution fractions were buffer exchanged to 20 mM sodium phosphate buffer (pH 7.4) using PD-10 Desalting Columns (GE Healthcare Life Sciences), following the manufacturer's instructions. Protein concentrations were assessed using the BCA Protein Assay Kit (Pierce Biotechnology; Thermo Fisher Scientific).
Bocillin FL PBP2a and penicillin G/clavulanic acid binding assays. The binding affinity of PBP2a for different antibiotics was previously determined using a fluorescent penicillin reporter reagent, Bocillin FL [55] [56] [57] . In this study, the affinities of PBP2A variants for penicillin and clavulanic acid were determined using the same approach. Briefly, a reaction mixture containing 25 μg ml −1 of a purified PBP2a variant in 20 mM sodium phosphate buffer (pH 7.4) and various concentrations (0, 0.5, 1, 5, 10, 20, 50, 100, 200, 500, 1,000 and 2,000 μg ml ) was added to the reaction followed by 10 min incubation at 37 °C. The reactions were quenched by adding sodium dodecyl sulfate loading buffer and heating at 95 °C for 10 min. Samples were visualized using 10% Tris-Glycine-SDS PAGE. Protein gels were washed in distilled water for 10 min and scanned using the 473 nm laser of a Fuji Fluorescent Analyzer TLA-5100. The fluorescence intensity was quantified by ImageJ software, and IC 50 was calculated from three independent assays using GraphPad Prism 5 software.
RNA isolation and RT-qPCR.
For each selected isolate, 15 ml of early log phase culture with an optical density measured at a wavelength of 595 nm (OD 595 ) of 0.3 was treated with 10 μg ml −1 oxacillin for 1 h at 37 °C to induce mecA expression, and its respective untreated culture was used as a baseline control. After the induction, the OD 595 of the control culture was adjusted to be equal to that of the oxacillininduced one if necessary, and 10 ml of both cultures was spun for 10 min at 4,500g at 20 °C. About 0.5 ml supernatant was left behind to resuspend the pellet, and 1 ml of RNAprotect Bacteria Reagent (Qiagen) was added and mixed immediately by vortexing. After incubation for 5 min at room temperature, cultures were spun for 5 min at 10,000g at 4 °C to pellet the cells. Pellets were snap-frozen and stored at −80 °C until RNA isolation. Total RNA was isolated using a Qiagen RNeasy Mini Kit. An additional DNAse treatment was performed with the Ambion TURBO DNA-free Kit and complementary DNA was produced using a QuantiTect Reverse Transcription Kit (Qiagen). RT-qPCR was performed using the SensiFAST SYBR No-ROX Kit (Bioline) on a Rotor-Gene Q machine (Qiagen) using mecA and blaZ primers. Gene expression fold-changes in induced cultures were calculated relative to control cultures using the 2 -ΔΔCt method 58 with gyrB as the reference.
Wax moth larva infection and treatment. The wax moth larvae assay was based on that previously described by Desbois et al. 59 . Galleria mellonella larvae were purchased in bulk from Livefood UK. Larvae were stored at 4 °C on arrival and kept at 37 °C during the course of the assay. MRSA strains RVC5, 0081, EC139 and BCVA289 were selected for evaluation of the antimicrobial activities of penicillin and clavulanic acid in combination. Single bacterial colonies were picked to inoculate 5 ml of TSB, and cultures were grown overnight (~16 h) at 37 °C with 200 r.p.m. shaking. Cultures were then diluted 1:100 into 5 ml of fresh . For each strain, six groups of G. mellonella (n = 10 in each group) were injected with 10 µl aliquots (~1.5 × 10 6 c.f.u.) of resuspended culture behind the rear thoracic segments using a Tridak Stepper Pipette Dispenser (Dymax). Groups of G. mellonella were treated by injection with 50 mg kg −1 vancomycin, 20 mg kg −1 penicillin sodium salt, 20 mg kg −1 clavulanic acid, 20 mg kg −1 penicillin sodium salt combined with 20 mg kg −1 clavulanic acid, 20 mg kg −1 amoxicillin, 20 mg kg −1 amoxicillin combined with 20 mg kg − 1 clavulanic acid or PBS at 2, 24 and 48 h after inoculation. The treatments were given blind and the treatment identities were not revealed until the experiment was completed. Larvae were considered dead when they did not respond to a touch to the head. Survival curves were generated and analysed using GraphPad Prism 6 software. Figure 5 shows the results of a single representative experiment. A replication experiment with broadly similar results is shown in Supplementary Fig. 5 .
Murine infection model. Fresh overnight colonies from a 5% horse blood agar plate were suspended in saline to an OD 546 of 0.13, giving approximately 2 × 10 8 c.f.u. ml ) for pain relief. Four mice in each group were treated with a single subcutaneous dose of 0.2 ml with 10, 30 or 100 mg kg −1 amoxicillin (Amoxil; GlaxoSmithKline) alone or in combination with 2, 6 or 20 mg kg −1 clavulanic acid (Augmentin; Beecham Group) or 40 mg kg −1 vancomycin (Fresenius Kabi) or saline 1 h post-infection. Mice were sacrificed by cervical dislocation at 1 h for the start of the treatment control group, and at 5 h post-infection for the treatment groups, and thighs were collected and kept at −80 °C. Each sample of thigh was homogenized in 5 ml saline using a Dispomix Drive and serially diluted in saline, and 20 µl spots of serial dilutions were plated on blood agar plates. All agar plates were incubated for 18-24 h at 35 °C. Statistical comparison was carried out using a one-way analysis of variance (ANOVA), and Dunnett's multiple comparison was performed for a comparison of the treatment groups with the vehicle group using GraphPad Prism software. All animal procedures were carried out at the Statens Serum Institute (SSI) and approved by the Danish Animal Procedure Inspectorate. Ethical approval was granted for the murine thigh infection model (2016-15-0201-01049). The SSI Animal Welfare Committee (equivalent to an Institutional Animal Care and Use Committee) requires that each experiment is further approved by the supervising laboratory animal veterinarians who are also part of the Institutional Animal Care and Use Committee. All animals were randomized on arrival at SSI, and sample sizes were based on a combination of statistical analysis and the principles of 3R (that is, that the minimum number of animals were used that were expected to provide a statistically significant difference considering the expected intragroup variability of the infection model used).
Growth curves. To assess the effects of different mecA variants on the growth of MRSA strains in liquid culture, a Bioscreen C optical growth analyzer (Labsystems) was used to monitor the growth rates of deletion mutants A75ΔmecA, BCVA289ΔmecA and EC139ΔmecA complemented with the three mecA variants. Briefly, overnight cultures were diluted 1/1,000 into fresh SSM9PR minimal medium, with or without 16 μg ml −1 penicillin supplemented with 200 ng ml −1 Atc, to induce the expression of the plasmid-borne mecA gene. For each strain, 300 μl of inoculated medium was added to the wells of the microplate in triplicate. Fresh medium with Atc was also added to three wells acting as blank controls. Cultures were incubated at 37 °C with continuous shaking for 24 h, and an optical density measurement at OD 600 was taken every 30 min. Growth curves were analysed using the GraphPad Prism 6 software, and the doubling time was calculated by nonlinear regression using an exponential growth equation with a least-squares fit, with Y0 (the value on the y axis at time 0) constrained at the minimum optical density measured (an OD 600 of 0.069).
Toxicity and biofilm assays. Immortalized human monocyte macrophage THP-1 cell lines were used as described previously 60 . Briefly, cell lines were grown in individual 30 ml suspensions of RPMI-1640 Medium, supplemented with 10% heat-inactivated foetal bovine serum, 1 μM l-glutamine, 200 U ml −1 penicillin and 0.1 mg ml −1 streptomycin at 37 °C in a humidified incubator with 5% CO 2 . Cells were routinely viewed microscopically every 48-60 h, harvested by centrifugation at 1,000 r.p.m. for 10 min at room temperature and resuspended to a final density of 1.0-1.2 × 10 6 cells ml −1 in tissue-grade PBS. This procedure typically yielded >95% viability of cells, as determined by trypan blue exclusion and easyCyte flow cytometry. To monitor S. aureus toxicity, 20 μl of cells were incubated with 20 μl of bacterial supernatant and incubated for 12 min at 37 °C. For the USA300 strains, supernatants were diluted to 30% of the original volume in TSB, as these isolates were considerably more toxic than the single-patient isolates. Cell death was quantified using easyCyte flow cytometry using the Guava viability stain according to the manufacturer's instructions. Experiments were performed in triplicate, and data indicate the average ± 95% CI of multiple independent experiments. Biofilm formation was quantified using a 1:40 dilution from overnight cultures into 100 µl of fresh TSB supplemented with 0.5% sterile filtered glucose in 96-well polystyrene plates (Costar). Perimeter wells of the 96-well plates were filled with sterile water, and the plates were placed in a separate plastic container inside a 37 °C incubator and grown for 24 h under static conditions. For the transposon mutants, erythromycin (5 µg ml ) was added to the growth medium. Semiquantitative measurements of biofilm formation on 96-well polystyrene plates were determined based on the method of Ziebuhr et al. 61 . Following 24 h of growth, plates were washed vigorously five times in PBS, dried and stained with 150 μl of 1% crystal violet for 30 min at room temperature. Following five washes of PBS, wells were resuspended in 200 μl of 7% acetic acid, and the OD 595 was recorded using a fluorometer plate reader (BMG LABTECH). For this experiment, the assays were performed in triplicate on each plate and repeated three times.
ECOFF determination.
To help split the isolates into phenotypically 'wild type' and 'non-wild type' based on MIC distributions, a series of mixture models were fitted to the data for each drug independently, ranging from one to five normal distributions. Each model was fit to the distribution of log-transformed MIC by maximum likelihood. The likelihood function was based on a multinomial distribution over the set of intervals [0,x 1 ,…,x n ,∞] where x i stands for each of the tested concentrations for the drug considered. For each drug, the five models were compared using Akaike's information criterion to determine the optimum number, k, of normal distribution components. If the best model was k = 1, the distribution was labelled as unimodal and no further analysis was made. For drugs with k ≥ 2, the following analyses were then carried out:
1. Predicted distribution of MIC per component. For each component, we multiplied the probability mass at each concentration (that is, probability density function (pdf) integrated over the immediately lower interval) by the total number of isolates tested. 2. Direct classification of isolates by component. For each MIC, we split the isolates into the k components according to their relative probabilities at that point. 3. Optimal cut-off. We then sought to split each distribution into two modes.
First, we estimated candidate cut-off points between each successive component of the mixture model. Each cut-off was computed as the concentration that minimized the risk of misclassification of isolates between the model components (achieved by minimizing the difference between the cumulative density functions of the two components considered). For example, with k = 3 (three components of the mixture model labelled 1, 2 and 3 in order of increasing mean MIC), we calculated two candidate cut-offs: one seperating commponent 1 from 2 + 3, and the other separating 1 + 2 from 3. For each cut-off, we then computed the number of isolates that would be misclassified, using the above direct classification as a reference (for example, for the first cut-off, the number of isolates classified as 2 or 3 with a MIC below the cutoff, plus the number of isolates classified as 1 with a MIC above the cut-off).
Bioinformatics. Whole-genome sequences were assembled using the pipeline described previously 62 . For each isolate, the sequence reads were used to create multiple assemblies using VelvetOptimiser version 2.2.5 (ref. 63 ) and Velvet version 1.2 (ref. 64 ). The assemblies were improved by scaffolding the best N50 and contigs using SSPACE 65 , and sequence gaps were filled using GapFiller 66 . PBP2a substitutions were identified by extracting the PBP2a sequence from the assembled genome sequences, aligning the PBP2a sequences using Muscle 67 in Seaview 68 and then identifying the presence of PBP2a substitutions using a custom python script. The mecA promoter mutations were identified with a similar approach using in silico PCR to identify the mecA promoter region and then aligning the mecA promoter sequence and identifying mecA mutations using a custom python script. The presence of the blaZ genes was confirmed using BLAST against assemblies. This identified that 273 out of 298 previously screened whole-genome-sequenced isolates had a single copy of blaZ (excluding blaZ-negative isolates or isolates with two copies or truncated copies of blaZ). 16, 69, 70 . Phylogenetic analysis of the CC8 isolates was carried out as previously described 32 . Briefly, sequence reads were mapped, using SMALT version 0.7.4 (http://www.sanger.ac.uk/science/tools/smalt-0), to the S. aureus USA300_ FPR3757 reference genome (accession: CP000255.1) 71 . A core genome alignment was created after excluding mobile genetic element regions, variable sites associated with recombination (detected with Gubbins
72
) and sites with more than a 5% proportion of gaps (that is, sites with an ambiguous base). A maximum-likelihood phylogenetic tree was generated with RAxML version 8.2.8 (ref. 73 ), based on a generalized time-reversible model with the GAMMA method of correction for among-site rate variation, and the phylogenetic tree was annotated using FigTree (http://tree.bio.ed.ac.uk/software/figtree/). Phylogenetic analysis of PBP2a sequences was constructed using PhyML version 3.0 in Seaview with a Whelan and Goldman substitution model and 100 bootstrap replicates 74 . Population analysis. Population analysis was carried out as described by Kim et al. 56 , with minor modifications. Strains were grown overnight in TSB, and serial tenfold dilutions were plated in triplicate onto ISA (Oxoid) plates containing varying concentrations of penicillin with 15 µg ml −1 clavulanic acid. Plates were incubated for 24 h at 35 °C. A mean of the three platings was plotted (Fig. 5a ). Biological replicates for strains BCVA289 and 0081 were generated and plotted compared with the original results in Supplementary Fig. 4 , showing broadly similar results.
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Structural modelling of PBP2a. Coordinates from representative structures of both the Gly246 (accession code 3ZFZ) 20 and Glu246 (accession code 1VQQ) 75 forms of PBP2a were used to compare possible effects induced by sidechain alteration.
Figures were prepared using Chimera 76 and PyMOL 1.2r3pre (https://pymol.org).
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
All data generated or analysed during this study are included in the published article and its Supplementary Information files. 
Data analysis
Growth curves, survival curves, mecA and blaZ expression data and murine experiment data were generated and analysed using GraphPad Prism 6 software. For the analysis of the Bocillin fluorescence intensity data, Image J (version 1.50b) and GraphPad Prism 5 Software was used.
InCyte software was used to analyze the flow cytometry data.
Structural modelling was carried out using The PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC. and Chimera (www.cgl.ucsf.edu/chimera/)
Whole genome sequences were assembled using the pipeline described previously (ref 62 68) and then identifying the presence of PBP2a substitutions using a custom python script. The mecA promoter mutations were identified using a similar approach using in silico PCR to identify the mecA promoter region and then aligning the mecA promoter sequence and identifying mecA mutations using a custom python script. The presence of the blaZ genes was confirmed using BLAST against assemblies, BlaZ amino acid sequences were then extracted, aligned and amino acids at positions 128 and Phylogenetic analysis of the CC8 isolates was carried out as previously described (ref 33) , briefly, sequence reads were mapped using SMALT v0.7.4 (http://www.sanger.ac.uk/science/tools/smalt-0) to the S. aureus USA300_FPR3757 reference genome (accession: CP000255.1) (ref 71 All studies must disclose on these points even when the disclosure is negative.
Sample size
For all in in vitro experiments at least three independent replicates were conducted. For murine experiments, sample sizes were based on a combination of statistical analysis and the principles of 3R, that the minimum number of animals were used that were expected to provide statistically significant difference considering the expected intra-group variability of the infection model used. For the wax moth infection model we used conducted each group contained 10 larvae and was independently replicated with similar results.
Data exclusions No data were excluded from analysis.
Replication
All attempts at replication were successful -as outlined above for all in vitro experiments at least three independent replicates were conducted with similar results. No further replication of murine experiments was conducted other than the data presented due to ethical constraints on the use of animals. Wax moth experiments were independently replicated with similar results.
Randomization Mice were randomized when unpacked at arrival to the animal facility. No other randomization was necessary in our experiments.
Blinding
For the wax moth larvae experiments the treatments were given blind and the treatment identities not revealed until the experiment was completed.
Reporting for specific materials, systems and methods Wild animals
The study did not involve wild animals.
Field-collected samples
The study did not involve field collected animals Flow Cytometry
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Methodology Sample preparation
Immortalised human monocyte macrophage THP-1 cell were grown in individual 30 mL suspensions of RPMI-1640, supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1 μM L-glutamine, 200 units/mL penicillin, and 0.1 mg/mL streptomycin at 37°C in a humidified incubator with 5% CO2. Cells were routinely viewed microscopically every 48-60 h and harvested by centrifugation at 1,000 rpm for 10 min at room temperature and resuspended to a final density of 1-1.2 x 106 cells/mL in tissue-grade phosphate buffered saline.
Instrument
Guava easyCyte flow cytometer
Software
InCyte software as provided with the Guava easyCyte flow cytometer Cell population abundance Trypan blue exclusion with a haemocytometer was used to both count cells and verify that our cell culturing proceedure yielded >95% viability.
Gating strategy
The cell acquisition gate was determined according to forward and side scatter channel to eliminate noise and debris. The live and dead cells were distinguished by fluorescent channels FL1 (live population SYTO9) vs FL3 (dead population PI). Population of live or dead cells were gated according to fluorescence minus one using single stains of SYTO9 and PI.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
